Park J H, Cho E W, Shin S Y, Lee Y J, Kim K L
Peptide Engineering Research Unit, Korea Research Institute of Bioscience and Biotechnology, Taejon, South Korea.
Biochem Biophys Res Commun. 1998 Mar 6;244(1):304-11. doi: 10.1006/bbrc.1998.8256.
The asialoglycoprotein receptor (ASGPR) is the first lectin discovered in mammals. Despite its significant biological role in binding and internalization of desialyated glycoproteins, at least in the human, little information is available regarding its tissue distribution outside of the liver. In the present study, antibodies were raised against the H1 major subunit of the human ASGPR using synthetic peptide antigens, and their binding specificity confirmed by enzyme linked immunosorbent assay. Cell surface analysis by fluorescence activated flow cytometry on various human tissue cell lines confirmed the liver parenchymal cells as the major expression site of ASGPR. Nonetheless, ASGPR was also detectable on some extrahepatic cells such as the Jurkat T-cell line. The determination of extrahepatic expression of ASGPR will have consequences in analyzing the biological role of this receptor complex as well as having implications in designing ASGPR mediated drug- or gene-delivery strategies.
去唾液酸糖蛋白受体(ASGPR)是在哺乳动物中发现的首个凝集素。尽管它在去唾液酸化糖蛋白的结合和内化过程中具有重要的生物学作用,至少在人类中是这样,但关于其在肝脏以外组织中的分布情况,目前所知甚少。在本研究中,使用合成肽抗原制备了针对人ASGPR H1大亚基的抗体,并通过酶联免疫吸附测定法确认了它们的结合特异性。通过荧光激活流式细胞术对各种人类组织细胞系进行细胞表面分析,证实肝实质细胞是ASGPR的主要表达位点。尽管如此,在一些肝外细胞如Jurkat T细胞系中也能检测到ASGPR。确定ASGPR的肝外表达将对分析该受体复合物的生物学作用产生影响,同时也对设计ASGPR介导的药物或基因递送策略具有重要意义。